Search results (7)
« Back to NewsOxford Cancer launches 2025 OCION Funding Scheme
13 June 2025
The 2025 Oxford Cancer Immuno-Oncology Network (OCION) Funding Scheme is now open!
New Study Finds Common Virus May Improve Skin Cancer Treatment Outcomes
23 April 2025
A new study led by the University of Oxford has revealed that a common and usually harmless virus may positively influence how skin cancer patients respond to current treatments.
Subashan Vadibeler wins 2024 Lasker Essay Contest
16 July 2024
Subashan Vadibeler, a recent Oxford Rhodes scholar and Department of Oncology student, is one of five co-winners of the international 2024 Lasker Essay Contest, sponsored by the Lasker Foundation.
Professor Eileen Parkes appointed to lead Oxford’s Experimental Cancer Medicine Centre
17 October 2023
Eileen Parkes, Associate Professor in Innate Tumour Immunology in the Department of Oncology, will lead the expansion of the centre’s programmes in early drug development and biomarker research.
Scientists find genetic ‘marker’ linked to serious side-effects from skin cancer treatment
16 December 2022
New research from the Fairfax Group has identified a genetic marker that could be used to predict a patient’s risk of developing serious side-effects when undergoing immunotherapy treatment for metastatic melanoma.
Department of Oncology to collaborate with Crescendo Biologics
20 September 2019
The Department of Oncology has signed up to collaborate with Crescendo Biologics Ltd (Crescendo), the drug developer of novel, targeted T cell enhancing therapeutics.
Study suggests immune system plays key role in survival after pancreatic cancer surgery
12 February 2019
Researchers in Oxford have found that an individual’s immune system – and in particular the presence of T-cells amongst tumour cells - may play an important role in survival after surgery to remove pancreatic cancer.